TIRZEPATIDE Pharmacologic Class Indexing
- Class set ID
- 16e8b468-25a6-43b5-a5fc-4bf89b0ef624
- Version
- 1
- Effective date
- 20230516
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 | Eli Lilly and Company | 20260422 | 38 |
| These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 | Eli Lilly and Company | 20260422 | 38 |